Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$2.6 - $3.91 $585 - $879
-225 Closed
0 $0
Q4 2020

Feb 26, 2021

BUY
$2.5 - $40.97 $562 - $9,218
225 New
225 $1,000
Q3 2020

Nov 13, 2020

SELL
$23.7 - $51.1 $5,332 - $11,497
-225 Closed
0 $0
Q4 2019

Mar 03, 2020

BUY
$5.38 - $9.29 $1,210 - $2,090
225 New
225 $2,000

About BiondVax Pharmaceuticals Ltd.


  • Ticker BVXV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,678,800
  • Market Cap $12M
  • Description
  • BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...
More about BVXV
Track This Portfolio

Track Rmr Wealth Builders Portfolio

Follow Rmr Wealth Builders and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmr Wealth Builders, based on Form 13F filings with the SEC.

News

Stay updated on Rmr Wealth Builders with notifications on news.